BioCentury
ARTICLE | Financial News

Neurochem files for IPO

June 1, 2000 7:00 AM UTC

Neurochem (St. Laurent, Quebec), which is developing treatments for amyloid-related diseases, filed to raise up to C$25 million (US$16.6 million) in a Canadian IPO. Loewen, Ondaatje, McCutcheon; and C...